Description
The Cambridge Biosafety Committee meets on the third Thursday of every month (one meeting for July/Aug) so that the members of the Cambridge Biosafety Committee may conduct oversight activities as granted by the Cambridge Recombinant DNA Technology Ordinance (Chapter 8.20) and the Cambridge Laboratory Biosafety Regulation (2009). The agenda for this meeting is CLOSED at this time., but please contact me 4-6 weeks in advance if you would like to be placed on a future agenda.
Register in advance and get remote access to this meeting:
https://cambridgema.zoom.us/webinar/register/WN_v_PEkGcpTheyGVLwi6BAhQ
Cambridge Biosafety Committee Meeting Agenda (Link to Meeting Agenda - PDF)
Thursday, January 20, 2022 – 3:00 p.m.
Introductions
Presentations
Clade Therapeutics (Kathryn Austgen) will present a request for a new BSL-2 ONLY permit
for their facility at One Kendall Square Bldg 300
Carmine Therapeutics (Tenzin Gocha) will present a request for a new BSL-2 ONLY permit
for their facility at 150 CambridgePark Drive, 7th Floor
Odyssey Therapeutics (Jena Gibson) will present a request for a new BSL-1/BSL-2 permit
for their facility at 301 Binney Street
Flagship Labs 90/ Flagship Labs 91 (Liam Casey, Joe Brady) will present a request for a new
BSL-2 ONLY permit for their facility at One Kendall Square Bldg 600-700 (Flagship
Foundry)
Old Business/Site visits
Jan 18 – Totus Medicine (1030 Massachusetts Ave, Ste 410) new BSL-1/BSL-2 permit walkthrough (presented on Dec 16, 2021)
New Business
Adjourn
*************************************************************************************************
Upcoming Meetings
2022
January 20
February 17
March 17
April 21
May 19
June 16